ESC 365 - Assessment of atrial and ventricular electromechanical delay, as a cardiotoxicity parameter in patients with trastuzumab chemotherapy for breast cancer patient.

HFA Premium Access

Assessment of atrial and ventricular electromechanical delay, as a cardiotoxicity parameter in patients with trastuzumab chemotherapy for breast cancer patient.

Session: Poster Session 2 - Co-morbidities

Topic: Cancer/Cardiotoxicity

Speaker: Doctor J. Choi (Pusan, KR)

Event: HEART FAILURE 2016

Congress Presentation

Add to my library

About the speaker

Doctor Jung-Hyun Choi

Pusan National University Hospital, Pusan (Korea (Republic of))

0 follower

31 more presentations in this session

Factors associated with medication adherence of elderly patients with chronic heart failure

Speaker: Professor V. Larina (Moscow, RU)

Renal denervation as a supportive treatmet to chronic heart failure

Speaker: Doctor P. Pietila-Effati (Vaasa, FI)

Heart failure and the risk of perioperative cardiovascular complications in noncardiac surgery

Contrast-induced nephropathy in a population with acute myocardial infarction and diabetes mellitus

Speaker: Doctor C. Arantes (Braga, PT)

Is there any benefit of early revascularization in patients with non-ST-elevation myocardial infarction and kidney disease?

Speaker: Doctor A. Correia (Barcelos, PT)

Access the full session

Poster Session 2 - Co-morbidities

Speakers: Doctor J. Choi, Professor V. Larina, Doctor P. Pietila-Effati, Doctor C. Arantes, Doctor A. Correia

About the event

HEART FAILURE 2016

21 May - 24 May 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources